(Q73223941)
Statements
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial (English)
G Boriani
M Biffi
A Capucci
G L Botto
T Broffoni
I Rubino
S Della Casa
M Sanguinetti